PRECLINICAL TOXICITY OF IRON CHELATORS: RFP AVAILABLE
Release Date: November 27, 2001
NOTICE: NOT-DK-01-017
National Institute of Diabetes and Digestive and Kidney Diseases
The National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) of the National Institutes of Health (NIH) is seeking an
organization or an institution to perform preclinical toxicity studies
of iron chelating compounds for potential use in the safe and effective
removal of iron deposits in patients with iron overload conditions
(e.g., Cooley"s anemia). A clinical evaluation is not desired at this
time. The contractor shall conduct toxicologic and related studies of
selected iron chelating compounds, in rats, dogs and other model
systems as directed by the Project Officer, and shall assist the NIDDK
and its scientific consultants by preparing reports based on the
resulting toxicologic information for submission as Investigational New
Drug applications (IND) to the Food and Drug Administration (FDA) for
approval of eventual clinical studies. The drugs under development are
considered to be orphan drugs. The Requests for Proposals, RFP No.
NIH-NIDDK-01-10 will be issued on or about November 9, 2001 with a
closing date on or about February 8, 2002. Requests for the RFP must
be in writing (by mail, fax, or e-mail) addressed to the Contracting
Officer cited below, and must cite the referenced RFP number.
Telephone requests will not be honored. All responsible sources may
submit a proposal that will be considered by the agency. The
Government is not committed to award a contract pursuant to this
announcement.
Robert T. Coonley, Contracting Officer
R&D Contracts Section, Acquisition Management Branch
National Institute of Diabetes, and Digestive and Kidney Diseases, NIH
2 Democracy Plaza, Room 780
6707 DEMOCRACY BLVD MSC 5455
BETHESDA, MD 20892-5455
Telephone: (301) 594-8837
Fax: (301) 480-8261
E-Mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||